Live Breaking News & Updates on Gore Associates

Stay updated with breaking news from Gore associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Hernia Repair Market Report 2024: A US$ 7.4 Billion

Dublin, May 20, 2024 (GLOBE NEWSWIRE) The ....

United-kingdom , France , Dublin , Ireland , Mexico , Germany , United-states , China , Brazil , Japan , India , America

ATOSS Software AG: Distribution of EUR 3.37 per share decided; approval for ATOSS Software AG to convert to a European Company (SE) and for a stock split; growth trajectory maintained in 2024

EQS-News: ATOSS Software AG

/ Key word: AGM/EGM

ATOSS Software AG: Distribution of EUR 3.37 per share decided; approval for ATOSS Software AG to convert to a European Company . ....

Munich , Bayern , Germany , Barry-callebaut , Gore-associates , Primark , Deutsche-bahn , Atoss-software , Lufthansa , European-company-societas-europaea , European-company , Management-board

ATOSS Software AG: Successful start to the 2024 fiscal year with double-digit growth in revenues and consistently high profitability in the first quarter

EQS-News: ATOSS Software AG

/ Key word: Quarterly / Interim Statement/Quarter Results

ATOSS Software AG: Successful start to the 2024 fiscal year with double-digit growth in. ....

Munich , Bayern , Germany , Barry-callebaut , Deutsche-bahn , Lufthansa , Gore-associates , Primark , Management-board , Annual-recurring-revenue , Annual-general-meeting , Markets

Vascular InterVentional Advances Conference, VIVA23, Clinical Trial Outcomes: PROMISE II (LimFlow) Trial for TADV, PRELUDE Study (LimbSonic) Therapeutic Ultrasound Presented

Results from five clinical trials were presented during the VIVA (Vascular InterVentional Advances) Conference, VIVA23, providing outcomes from studies on treatment for chronic limb-threatening ischemia (CLTI), use of drug-coated balloons, among other highly-anticipated late-breaking science findings. ....

Switzerland , New-zealand , Japan , Germany , United-states , Japanese , Mahmood-razavi , Gore-viabahn , Anvar-babaev , Thomas-zeller , Daniel-clair , Osamu-iida

First Round of Late-Breaking Clinical Trial Results Announced at VIVA23

/PRNewswire/ The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and. ....

Switzerland , Japan , United-states , Germany , New-zealand , Japanese , Thomas-zeller , Daniel-clair , Anvar-babaev , Osamu-iida , Gore-viabahn , Mahmood-razavi